🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jinan
Clinical trial register · China

Clinical Trials in Jinan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Qilu Hospital of Shandong University114 Qianfoshan Hospital32 Shandong Cancer Hospital and Institute31 AstraZeneca26 Shandong University26
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Jinan

785 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC
NCT07009145Unresectable Colorectal Cancer, Metastatic Colorectal Cancer (CRC), MSI-H/dMMR Colorectal Cancer
Qianfoshan Hospital
Phase 2
22
Jinan
2025-06-27
Not yet open
Effects of Integrative Neuromuscular Traning on Physical Fitness and Dribbling Performance Among High School Male Football Players in Shandong, China
NCT07017049Adolescent, Healthy Volunteers (HV), Physical Fitness and Technical Skills, Football Players
Xinrui Zhang
Not applicable
70
Jinan
2025-06-20
Active, closed
JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
NCT06969027Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
69
Jinan
2025-06-19
Recruiting
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
NCT06940336Transthyretin Amyloid Polyneuropathy
Qilu Pharmaceutical Co., Ltd.
Phase 4
15
Jinan
2025-06-19
Recruiting
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
NCT06975748Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 2
48
Jinan
2025-06-12
Recruiting
Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases
NCT06978231Pancreaticobiilary Diseases
Qilu Hospital of Shandong University
Not applicable
214
Jinan
2025-06-10
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222Leukemia, Myeloid, Acute
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Jinan
2025-06-04
Not yet open
Efficacy and Safety of Robot-assisted Endoscopic Submucosal Dissection for Colorectal Neoplasm
NCT06973083Robot Surgery, Endoscopic Submucosal Dissection (ESD), Colorectal Neoplasms
Shandong University
Not applicable
104
Jinan
2025-06-01
Not yet open
Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization
NCT06990685Salidroside, Randomized Controlled Trial, In Vitro Fertilization, Assisted Reproductive Technology
The Second Hospital of Shandong University
Phase 2
370
Jinan
2025-06-01
Recruiting
SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue
NCT06987370Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute
Not applicable
90
Jinan
2025-06-01
Not yet open
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial
Peking University People's Hospital
Not applicable
1,389
Beijing, Chongqing, Handan, Harbin, Wuhan, Changchun, Jinan, Qingdao
2025-06
Active, closed
A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy
NCT06945107Plaque Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
308
Jinan
2025-05-27
Recruiting
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
NCT06943677Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Nanjing, Nanchang, Xi'an, Heze, Jinan
2025-05-26
Recruiting
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury
NCT06847555To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
Shandong Cancer Hospital and Institute
Phase 1/2
24
Jinan
2025-05-25
Active, closed
A Study for HSK44459 in Participants With Atopic Dermatitis
NCT06996912Atopic Dermatitis (AD)
Xizang Haisco Pharmaceutical Co., Ltd
Phase 2
150
Jinan
2025-05-22
Recruiting
A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
NCT07340424Advanced Metastatic Triple-negative Breast Cancer (mTNBC)
Xiaorong Sun
Phase EARLY_PHASE1
15
Jinan
2025-05-22
Active, closed
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179Obesity/Overweight
AstraZeneca
Phase 2
14
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Not yet open
Effect of Opioid-free Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery
NCT06958393Delirium - Postoperative, Opioid-Free Anaesthesia
Qianfoshan Hospital
Phase 4
406
Jinan
2025-05-20
Recruiting
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
NCT06980259Soft Tissue Sarcoma (STS)
Shandong Cancer Hospital and Institute
Not applicable
106
Jinan
2025-05-20
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT06972472Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
600
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-19
Active, closed
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
NCT06898957Small Cell Lung Cancer
Amgen
Phase 1
29
Jinan, Chengdu, Fuzhou
2025-05-16
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
NCT06993792Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
1,400
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
NCT06972459Obesity, Overweight
Eli Lilly and Company
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Recruiting
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
NCT07040332Allergic Bronchopulmonary Aspergillosis (ABPA)
Qianfoshan Hospital
Observational
140
Jinan
2025-05-10
Recruiting
Clinical Trial of PCV24 in Infants Aged 2-23 Months
NCT06800261Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.
Phase 1
180
Jinan, Shancheng
2025-05-08
Recruiting
Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
NCT06840821Advanced Solid Tumors
Mainline Biosciences (Shanghai) Co., Ltd
Phase 1/2
156
Jinan
2025-05-08
Recruiting
A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia
NCT06853444Immune Thrombocytopenia (ITP)
Shanghai Escugen Biotechnology Co., Ltd
Phase 1/2
84
Jinan
2025-05-08
Active, closed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT06799286Small Cell Lung Carcinoma
Bristol-Myers Squibb
Phase 1
10
Beijing, Jinan, Linyi, Hangzhou, Shanghai
2025-05-07
Recruiting
Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma
NCT07000643Nasopharyngeal Carcinoma
Man Hu
Phase 3
386
Jinan
2025-05-07
Not yet open
Efficacy and Safety of Cold Versus Hot Snare Polypectomy for Removal of 4-10 mm Pedunculated Colorectal Polyps
NCT06937047Colorectal Polyps
Shandong University
Not applicable
196
Jinan
2025-05-06
Recruiting
Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation
NCT06938243Stroke, Motor Rehabilitation
Qilu Hospital of Shandong University
Phase 1
100
Jinan
2025-05-01
Not yet open
The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP
NCT06913374Thrombocytopenia
Shandong University
Phase 2/3
118
Jinan
2025-05-01
Recruiting
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
NCT06802757Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2
72
Jinan
2025-05-01
Recruiting
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC
NCT06709859Carcinoma, Non-Small-Cell Lung
Shandong Public Health Clinical Center
Phase 2
30
Jinan
2025-05-01
Not yet open
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690Rectal Cancer, Surgery
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
NCT06948435Hypertension, Overweight or Obesity
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
NCT06907043Advanced Solid Tumors
Eikon Therapeutics
Phase 1/2
130
Chongqing, Jinan, Shanghai
2025-04-30
Recruiting
Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)
NCT07026422Rectal Malignant Neoplasms
Shandong Cancer Hospital and Institute
Phase 2
54
Jinan
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530Hypertension
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
NCT06948422Hypertension
Eli Lilly and Company
Phase 3
974
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
NCT06623136Non-Small Cell Lung Cancer
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
40
Beijing, Zhengzhou, Nanchang, Changchun, Jinan, Luoyang, Taiyuan, Taizhou
2025-04-30
Recruiting
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
NCT06963281Solid Tumors
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 1
285
Guangzhou, Jinan, Taiyuan
2025-04-29
Recruiting
Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury
NCT06978205Spinal Cord Injuries (SCI), Urinary Bladder, Neurogenic, Urinary Retention
Qilu Hospital of Shandong University
Not applicable
74
Jinan
2025-04-28
Recruiting
Neoadjuvant QL1706 Therapy for ESCC
NCT06908382Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital
Phase 2
32
Jinan
2025-04-28
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489Large Vessel Occlusion, Acute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College
Observational
500
Wuhu, Baotou, Jinan, Henan, Beijing
2025-04-27
Active, closed
Combined Cyclic Compression Cryotherapy and Phased Rehabilitation Training for Recovery After Knee Replacement
NCT07089212Knee Arthroplasty, Total, Rehabilitation Therapy
Qilu Hospital of Shandong University
Not applicable
100
Jinan
2025-04-23
Recruiting
Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR
NCT06711016Cardiac Arrest
Qilu Hospital of Shandong University
Not applicable
654
Jinan
2025-04-22
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06857279Carcinoma of Head and/or Neck
Shanghai Henlius Biotech
Phase 2
167
Jinan, Shanghai
2025-04-22
Recruiting
A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease
NCT06900010Autoimmune Bullous Disease
Shandong First Medical University
Phase 2
30
Jinan
2025-04-22
Recruiting
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
NCT06772064SIBO
Xiuli Zuo
Not applicable
115
Jinan
2025-04-15
Recruiting
MCG for Non-Obstructive Myocardial Ischemia
NCT07657546Myocardial Ischemia
Qilu Hospital of Shandong University
Observational
3,786
Jinan
2025-04-15
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
NCT05066217Lennox Gastaut Syndrome
Epygenix
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Jinan
2025-04-09
Recruiting
Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate
NCT06961149Colonic Polyps, Adenomatous Polyps, Adenoma Detection Rate, Chromoendoscopy
Shandong University
Not applicable
352
Jinan
2025-04-08
Recruiting
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
NCT06900062Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,500
Guiyang, Changchun, Jinan, Shanghai, Jiaxing
2025-04-06
Not yet open
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
NCT06917495Mild Spinal Tuberculosis
Shandong University
Phase 2
300
Jinan
2025-04-05
Recruiting
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
NCT06907628Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
150
Jinan
2025-04-02
Recruiting
Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes
NCT06922526Tricuspid Regurgitation, Pacemaker
Haiyan Wang
Observational
200
Jinan
2025-04
Recruiting
Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial
NCT06932328Acute Pharyngitis
Jianmin Pharmaceutical Group Co., LTD.
Phase 2
216
Harbin, Changsha, Changchun, Jinan, Luzhou, Tianjin, Wenzhou
2025-03-26
Recruiting
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma
NCT06932068HER2 Negative, Low PD-L1 Expressing, Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University
Phase 2
77
Zhengzhou, Binzhou, Dezhou, Dongying, Jinan, Jining, Liaocheng, Linyi
2025-03-26
Recruiting
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
NCT06895499Hidradenitis Suppurativa
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1/2
15
Jinan
2025-03-19
Active, closed
cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
NCT06686485Concomitant Procedures, Atrial Fibrillation, PFA, LAAC
Boston Scientific Corporation
Observational
433
Suzhou, Beijing, Chengdu, Guangzhou, Guiyang, Hangzhou, Jinan, Kunming
2025-03-18
Recruiting
Gut Microbiota in IBD With Comorbid Depressive Disorder
NCT07252427Inflammatory Bowel Disease, Depressive Disorder
Fang Tang
Observational
120
Jinan
2025-03-16
Not yet open
Reducing Pneumonia with LMA in Lung Wedge Resection
NCT06873958Pneumonia, Postoperative, Anesthesia, Thoracic Surgery, Thoracoscopic Wedge Resection
Hai Feng
Observational
700
Jinan
2025-03-15
Recruiting
A Study of SHR-A1811 in Subjects With Ovarian Cancer
NCT06828354Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
300
Wuhan, Jinan
2025-03-13
Active, closed
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
NCT06771622Solid Cancer
FBD Biologics Limited
Phase 1/2
500
Jinan
2025-03-13
By invitation
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
NCT06883136Non-Small Cell Lung Cancer
Qianfoshan Hospital
Observational
43
Jinan
2025-03-12
Recruiting
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06829797Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Shandong Provincial Hospital
Phase 2
96
Jinan
2025-03-11
Recruiting
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
NCT06738966Breast Cancer, Ovarian Cancer, Endometrial Cancer
Shanghai Best-Link Bioscience, LLC
Phase 1
9
Changchun, Jinan
2025-03-10
Recruiting
Progesterone-modified Natural Cycle for FET
NCT06644794Infertility, Female
Shandong University of Traditional Chinese Medicine
Phase 3
336
Jinan
2025-03-05
Recruiting
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
NCT06688435Myasthenia Gravis
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
60
Jinan
2025-03-04
Recruiting
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509Esophageal Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,450
Guangzhou, Nanchang, Shenyang, Jinan, Shanghai
2025-03-01
Recruiting
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
NCT06521866Advanced Colorectal Carcinoma, Immunotherapy
Fudan University
Phase 2
208
Fuzhou, Xiamen, Lanzhou, Zhengzhou, Huaian, Jinan, Taian, Shanghai
2025-03-01
By invitation
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)
NCT06936800Chronic Pancreatitis, Pancreatic Duct Stones
Yanqing Li
Not applicable
288
Jinan
2025-03-01
Not yet open
Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients
NCT06881680Stroke
Qilu Hospital of Shandong University
Not applicable
120
Jinan
2025-03
Recruiting
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
NCT06942416Cervical Cancer, Neoplasm Recurrence, Local, Oligometastatic
Shandong Cancer Hospital and Institute
Phase 2
36
Jinan
2025-02-28
Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478Gastric Cancer, Gastroesophageal Junction Cancer
Daiichi Sankyo
Phase 3
726
Beijing, Changzhou, Fuzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou
2025-02-27
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552Advanced Solid Tumors, Platinum Resistant Ovarian Cancer, Fallopian Tube Cancer, Renal Cell Carcinoma (RCC)
NextCure, Inc.
Phase 1
738
Beijing, Shenyang, Shijiazhuang, Guangzhou, Changsha, Jinan, Jining, Shanghai
2025-02-26
Recruiting
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
NCT06873659Solid Tumor, Gastric Cancer, Liver Cancer
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
NCT06848699Solid Tumor Cancer, Non Small Cell Lung Cancer
Shanghai Henlius Biotech
Phase 1/2
105
Hunan, Jinan, Chongqing
2025-02-25
Active, closed
A Trial of SHR0302Base in Patients With Vitiligo
NCT06790862Vitiligo
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
155
Jinan
2025-02-13
Recruiting
Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
NCT06844422Pancreatic Cancer
Shandong Cancer Hospital and Institute
Phase 1/2
37
Jinan
2025-02-08
Active, closed
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
NCT06834360Chronic Rhinosinusitis With Nasal Polyps
Sanofi
Phase 3
216
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Jinan, Jingzhou, Nanning
2025-02-06
Recruiting
SKB445 for Injection in Solid Tumors
NCT06826040Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
126
Jinan
2025-02-05
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
NCT06624670Pyoderma Gangrenosum
LEO Pharma
Phase 3
90
Beijing, Changchun, Changsha, Chengdu, Hangzhou, Jinan, Shanghai, Shenzhen
2025-02-05
Recruiting
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
NCT06816771Rhabdomyosarcoma, Recurrent, Refractory
Shandong Cancer Hospital and Institute
Phase 2
38
Jinan
2025-02
Recruiting
A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
NCT07362693ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA), Cohort Study
Qianfoshan Hospital
Observational
50
Jinan
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Beijing, Guangzhou, Jinan, Tianjin, Zhengzhou
2025-01-30
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
NCT06769113Esophageal Cancer
Shanghai Henlius Biotech
Phase 2
102
Jinan
2025-01-26
Active, closed
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
NCT06587438Diabetes Mellitus
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT06754644NSCLC
Qilu Pharmaceutical Co., Ltd.
Phase 3
808
Jinan
2025-01-15
Recruiting
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06418061Unresectable, Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
198
Jinan
2025-01-08
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
NCT06772415Advanced Solid Tumor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
BioNTech SE
Phase 2/3
1,580
Baoding, Beijing, Changchun, Hangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-01-07
Recruiting
A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors
NCT07229898Advanced Solid Tumors
Henan Genuine Biotech Co., Ltd.
Phase 1
48
Harbin, Jinan, Shanghai, Xinxiang
2025-01-07
Recruiting
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Antiphospholipid (aPL)-Positive, Thrombocytopaenia
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, Ürümqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Effects of Different Modes of Action Observation Therapy on Swallowing Function After Stroke: a Study Based on fNIRS
NCT07184892Stroke
Qilu Hospital of Shandong University
Not applicable
90
Jinan
2025-01-06
Recruiting
A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
NCT07017725Chronic Immune Thrombocytopenia
CASI pharmaceuticals, Inc.
Phase 1/2
75
Tangshan, Zhengzhou, Nanchang, Jinan, Tianjin, Kunming
2025-01-03
Recruiting
The Impact of Methylene Blue on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy
NCT06747195Hemorrhoidectomy, Postoperative Analgesia
Qilu Hospital of Shandong University
Observational
290
Heze, Jinan, Weifang
2025-01-01
Rows per page Showing 301–400 of 785
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/jinan?page=4

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 785 of those studies with a site in Jinan.

How many clinical trials are recruiting in Jinan?

488 of the 785 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 130 have not yet opened recruitment, 149 are active but closed to new participants, and 18 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.